Low dose Ibuprofen for patients ≥65 years of age

Generally, NSAID use is not routinely restricted in the elderly patient population. That said, additional clinical consideration should be given to a patient’s overall health status, medication history, current medication use, and comorbidities. As with any medication, it is essential to weigh the potential benefits and risks, particularly in patients aged 65 years and older, as this population faces additional risk factors.

NSAIDs are widely recognized as medications that should be used cautiously in older adults and ideally for limited durations due to an increased risk of adverse effects, including gastrointestinal bleeding, renal impairment, and heart failure. Evidence suggests that many complications associated with NSAID use in the elderly are primarily linked to repeated and/or daily use rather than single or short-term dosing. For this reason, obtaining a thorough medication history—including information on daily or chronic NSAID use—is critical prior to administering ibuprofen or other NSAIDs.

One of the primary concerns with NSAID administration in patients aged 65 years and older is the potential for worsening renal function. Data from the National Kidney Foundation’s Kidney Early Evaluation Program (KEEP) reported that the prevalence of chronic kidney disease in individuals aged 65 and older was approximately 44% between 2000 and 2008. Many older adults experience age-related declines in renal function but may be unaware of this, making careful risk–benefit assessment especially important before administering NSAIDs.

When considering analgesia, initiating treatment with a lower dose, such as 200 mg of ibuprofen instead of 400 mg, is a reasonable approach. A 200 mg dose has been shown to provide adequate pain relief in many cases and may be an effective component of a multimodal analgesia strategy. If a reduced dose is chosen, the rationale for the dosing variance should be clearly documented. That said, a single 400 mg dose of ibuprofen is still considered safe in patients aged 65 years and older, as one-time dosing rarely results in significant adverse effects. This rationale is reflected in the dosage recommendations outlined in the ALS PCS. You can also consider prioritizing using acetaminophen, but still, adding a one-time low dose NSAID is considered reasonable and safe for this patient population.